Proposed Amendment to ADB’s Support to Enhance COVID-19 Vaccine Access

Institutional Document | April 2021

Given the developments since the start of the pandemic, ADB Management considers this an opportune time to review and update the APVAX vaccine eligibility criteria and requests Board approval to modify the criteria.


  • Introduction
  • Background
  • Proposed Amendments and Rationale
  • Recommendation

Additional Details

  • ADB funds and products
  • Health
  • Communicable and vector-borne diseases
  • Emerging diseases
  • COVID-19

Subscribe to our monthly digest of latest ADB publications.

Follow ADB Publications on social media.